FDA Inspection
LGM Pharma Solutions LLCLGM Pharma Solutions LLC – FDA Inspection, Feb 7, 2017
Record Details
This FDA Inspection record concerns LGM Pharma Solutions LLC, with an inspection on February 7, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6421a337-4fc1-4056-9b4f-6168f2d6aa0e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1006806
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of LGM Pharma Solutions LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2025 | VAI | Dallas District Office | Drug Quality Assurance |
| December 3, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LGM Pharma Solutions LLC
- FDA Inspection 1252090 - 2025-08-06
- FDA Inspection 1078278 - 2018-12-03
- FDA Inspection 928739 - 2015-05-29
- FDA Inspection 817511 - 2013-02-05
- FDA Inspection 679456 - 2010-09-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.